» Articles » PMID: 29566601

Investigation of Microbiota Alterations and Intestinal Inflammation Post-Spinal Cord Injury in Rat Model

Overview
Journal J Neurotrauma
Publisher Mary Ann Liebert
Date 2018 Mar 24
PMID 29566601
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Although there has been a significant amount of research focused on the pathophysiology of spinal cord injury (SCI), there is limited information on the consequences of SCI on remote organs. SCI can produce significant effects on a variety of organ systems, including the gastrointestinal tract. Patients with SCI often suffer from severe, debilitating bowel dysfunction in addition to their physical disabilities, which is of major concern for these individuals because of the adverse impact on their quality of life. Herein, we report on our investigation into the effects of SCI and subsequent antibiotic treatment on the intestinal tissue and microbiota. For that, we used a thoracic SCI rat model and investigated changes to the microbiota, proinflammatory cytokine levels, and bacterial communication molecule levels post-injury and gentamicin treatment for 7 days. We discovered significant changes, the most interesting being the differences in the gut microbiota beta diversity of 8-week SCI animals compared to control animals at the family, genus, and species level. Specifically, 35 operational taxonomic units were enriched in the SCI animal group and three were identified at species level; Lactobacillus intestinalis, Clostridium disporicum, and Bifidobacterium choerinum. In contrast, Clostridium saccharogumia was identified as depleted in the SCI animal group. Proinflammatory cytokines interleukin (IL)-12, macrophage inflammatory protein-2 (MIP-2), and tumor necrosis factor alpha were found to be significantly elevated in intestinal tissue homogenate 4 weeks post-SCI compared to 8-weeks post-injury. Further, levels of IL-1β, IL-12, and MIP-2 significantly correlated with changes in beta diversity 8-weeks post-SCI. Our data provide a greater understanding of the early effects of SCI on the microbiota and gastrointestinal tract, highlighting the need for further investigation to elucidate the mechanism underlying these effects.

Citing Articles

Biomarker expression level changes within rectal gut-associated lymphoid tissues in spinal cord-injured rats.

Zhou Y, Hubscher C Immunohorizons. 2025; 9(4).

PMID: 40048710 PMC: 11884801. DOI: 10.1093/immhor/vlaf002.


Spinal cord injury: pathophysiology, possible treatments and the role of the gut microbiota.

Pagan-Rivera L, Ocasio-Rivera S, Godoy-Vitorino F, Miranda J Front Microbiol. 2025; 15():1490855.

PMID: 39744391 PMC: 11688470. DOI: 10.3389/fmicb.2024.1490855.


Prussian blue nanotechnology in the treatment of spinal cord injury: application and challenges.

Gu X, Zhang S, Ma W Front Bioeng Biotechnol. 2024; 12:1474711.

PMID: 39323764 PMC: 11422158. DOI: 10.3389/fbioe.2024.1474711.


Diet-microbiome interactions promote enteric nervous system resilience following spinal cord injury.

Hamilton A, Blackmer-Raynolds L, Li Y, Kelly S, Kebede N, Williams A NPJ Biofilms Microbiomes. 2024; 10(1):75.

PMID: 39209925 PMC: 11362535. DOI: 10.1038/s41522-024-00556-y.


Crosstalk between gut microbiota and host immune system and its response to traumatic injury.

Ullah H, Arbab S, Tian Y, Chen Y, Liu C, Li Q Front Immunol. 2024; 15:1413485.

PMID: 39144142 PMC: 11321976. DOI: 10.3389/fimmu.2024.1413485.


References
1.
Walter J . Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research. Appl Environ Microbiol. 2008; 74(16):4985-96. PMC: 2519286. DOI: 10.1128/AEM.00753-08. View

2.
Gris D, Hamilton E, Weaver L . The systemic inflammatory response after spinal cord injury damages lungs and kidneys. Exp Neurol. 2008; 211(1):259-70. DOI: 10.1016/j.expneurol.2008.01.033. View

3.
Org E, Mehrabian M, Parks B, Shipkova P, Liu X, Drake T . Sex differences and hormonal effects on gut microbiota composition in mice. Gut Microbes. 2016; 7(4):313-322. PMC: 4988450. DOI: 10.1080/19490976.2016.1203502. View

4.
Raut N, OConnor G, Pasini P, Daunert S . Engineered cells as biosensing systems in biomedical analysis. Anal Bioanal Chem. 2012; 402(10):3147-59. DOI: 10.1007/s00216-012-5756-6. View

5.
Middleton J, Lim K, Taylor L, Soden R, Rutkowski S . Patterns of morbidity and rehospitalisation following spinal cord injury. Spinal Cord. 2004; 42(6):359-67. DOI: 10.1038/sj.sc.3101601. View